Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Down-regulation of protease-activated receptor 4 in lung adenocarcinoma is associated with a more aggressive phenotype.

Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2013

Jiang Ping, Yu Guo-Yu, Zhang Yong, Xiang Yang, Hua Hai-Rong, Bian Li, Wang Chun-Yan, Lee Wen-Hui, Zhang Yun

Abstract excerpt

The role of protease-activated receptors (PARs) in lung tumors is controversial. Although PAR4 is preferentially expressed in human lung tissues, its possible significance in lung cancer has not been defined. The studies reported herein used a combination of clinical observations and molecular methods. Surgically resected lung adenocarcinomas and associated adjacent normal lung tissues were collected and BEAS-2B...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Follow-Up Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, Tumor Suppressor

Share to Immunoenzyme Techniques

Share to Lymphatic Metastasis

Share to Neoplasm Staging

Share to Real-Time Polymerase Chain Reaction

Share to Receptors, Thrombin

Source

Identifiers

PMID: 23886184
DOI: 10.7314/apjcp.2013.14.6.3793

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Down-regulation of protease-activated receptor 4 in lung adenocarcinoma is associated with a more aggressive phenotype.PMID 23886184Read ↗

PAR1 and PAR4 exert opposite effects on tumor growth and metastasis of esophageal squamous cell carcinoma via STAT3 and NF-κB signaling pathwaysSemantic proximity Read ↗

Expression of proteinase-activated receptor 1-4 (PAR 1-4) in human cancerSemantic proximity Read ↗

Cell adhesion and polarity in squamous cell carcinoma of the lung.Semantic proximity Read ↗

GPCRs in Cancer: Protease-Activated Receptors, Endocytic Adaptors and SignalingSemantic proximity Read ↗

TMPRSS4, a type II transmembrane serine protease, as a potential therapeutic target in cancerSemantic proximity Read ↗

Apoptosis and tumor resistance conferred by Par-4Semantic proximity Read ↗

Proteinase-activated receptor 4 stimulation-induced epithelial-mesenchymal transition in alveolar epithelial cells.Semantic proximity Read ↗

SERPINB5 is a prognostic biomarker and promotes proliferation, metastasis and epithelial‐mesenchymal transition ( EMT) in lung adenocarcinomaSemantic proximity Read ↗

Matrix metalloproteinase-10 is a critical effector of protein kinase Cι-Par6α-mediated lung cancerSemantic proximity Read ↗

Profiling Gene Expression Induced by Protease-Activated Receptor 2 (PAR2) Activation in Human Kidney CellsSemantic proximity Read ↗

Cloning and characterization of human protease-activated receptor 4.Semantic proximity Read ↗

Downregulation of PAR-4, a pro-apoptotic gene, in pancreatic tumors harboring K-ras mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.